IL-4: Proteins and Enzymes
IL-4 (Interleukin-4) is a cytokine that is primarily expressed by Th2-biased CD4+ T cells, mast cells, basophils, and eosinophils. It promotes cell proliferation, survival, and immunoglobulin class switch to IgG4 and IgE in human B cells, acquisition of the Th2 phenotype by naïve CD4+ T cells, priming and chemotaxis of mast cells, eosinophils, and basophils, and the proliferation and activation of epithelial cells. IL-4 plays a dominant role in the development of allergic inflammation and asthma. The type I receptor for IL-4, which is expressed on hematopoietic cells, is a heterodimer of the ligand binding IL-4 R alpha and the common gamma chain (a shared subunit of the receptors for IL-2, -7, -9, -15, and -21). The type II receptor on nonhematopoietic cells consists of IL-4 R alpha and IL-13 R alpha 1. The type II receptor also transduces IL-13 mediated signals.
17 results for "IL-4 Proteins and Enzymes" in Products
Search
Application
Conjugates
Low Endotoxin
Sample Size
Citations
Reviews
IL-4: Proteins and Enzymes
IL-4 (Interleukin-4) is a cytokine that is primarily expressed by Th2-biased CD4+ T cells, mast cells, basophils, and eosinophils. It promotes cell proliferation, survival, and immunoglobulin class switch to IgG4 and IgE in human B cells, acquisition of the Th2 phenotype by naïve CD4+ T cells, priming and chemotaxis of mast cells, eosinophils, and basophils, and the proliferation and activation of epithelial cells. IL-4 plays a dominant role in the development of allergic inflammation and asthma. The type I receptor for IL-4, which is expressed on hematopoietic cells, is a heterodimer of the ligand binding IL-4 R alpha and the common gamma chain (a shared subunit of the receptors for IL-2, -7, -9, -15, and -21). The type II receptor on nonhematopoietic cells consists of IL-4 R alpha and IL-13 R alpha 1. The type II receptor also transduces IL-13 mediated signals.
17 results for "IL-4 Proteins and Enzymes" in Products
Source : | E. coli |
Accession # : | P05112.1 |
Applications : | Bioactivity |
Intended for preclinical researchers who may transition to GMP IL-4 for their clinical work
Source : | E. coli |
Accession # : | P05112.1 |
Applications : | Bioactivity |
Source : | E. coli |
Accession # : | P07750 |
Applications : | Bioactivity |
Source : | E. coli |
Accession # : | P05112.1 |
Applications : | Bioactivity |
Source : | CHO |
Accession # : | P05112 |
Applications : | Bioactivity |
Source : | E. coli |
Accession # : | AAD11563 |
Applications : | Bioactivity |
Source : | E. coli |
Accession # : | Q04745 |
Applications : | Bioactivity |
Source : | E. coli |
Accession # : | P20096.2 |
Applications : | Bioactivity |
Source : | E. coli |
Accession # : | NP_001156649 |
Applications : | Bioactivity |
Source : | E. coli |
Accession # : | NP_001075988 |
Applications : | Bioactivity |
Source : | E. coli |
Accession # : | P51492 |
Applications : | Bioactivity |
Source : | E. coli |
Accession # : | P30367.2 |
Applications : | Bioactivity |
Source : | E. coli |
Accession # : | P55030 |
Applications : | Bioactivity |
Source : | E. coli |
Accession # : | AAL18820 |
Applications : | Bioactivity |
Source : | E. coli |
Accession # : | P05112 |
Applications : | Bioactivity |
Animal-Free. Earn double rewards for reviews
Source : | E. coli |
Accession # : | P05112.1 |
Applications : | Bioactivity |
Source : | E. coli |
Accession # : | P05112.1 |
Applications : | Bioactivity |